The CM Group Buys Scientific Commercialization

CM Group

The CM Group, LLC, a Hingham, Mass.-based provider of information and knowledge services to the biopharmaceutical community, acquired Scientific Commercialization, LLC, a Madison, Wisconsin-based provider of medical affairs consulting and business intelligence software solutions.

The amount of the deal was not disclosed.

The acquisition will provide life science companies with a comprehensive suite of offerings coupled with the personalized service. The deal marks a further step in The CM Group’s growth strategy. In 2017, the company launched the Px Group, a division focused on integrating authentic patient and caregiver voices through all stages of a company’s pre-commercial and commercial activities. Activities includes patient/caregiver advisory boards, 1:1 insight sessions, peer-to-peer meetings, mentor/buddy programs, advocacy relationship management, patient story development, podcasts, videos, websites and more.

Led by Daniel Leonard, former CEO and current Member of the Board of The CM Group focused on Corporate Development, Scientific Commercialization provides innovative consulting and analytics to medical affairs and other functions within life sciences and biopharmaceutical companies, including a wide range of services from product strategy, launch and execution to organizational design and process optimization. In addition, they offer a suite of business intelligence solutions—including SC-Insight®, social listening and Natural Language Processing—empowering clients to optimize data and bring forward insights that provide real impact to patient and company success.

Led by Cherie Myatt and Maggie Butler, The CM Group designs and executes programs for the life sciences industry, which facilitate meaningful engagements — from Speaker Programs for physicians and patients to KOL Roundtables to National Sales Meetings.